Earnings

Credo Plunges 20% on Valuation Worries Despite Record Revenue

Credo Technology shares tumbled 20% on Wednesday despite record revenue, as investors balked at a rich valuation and declining GAAP margins. Analysts remain bullish, but concentration risk looms.

James Calloway · · · 3 min read · 19 views
Credo Plunges 20% on Valuation Worries Despite Record Revenue
Mentioned in this article
ALAB $274.13 -2.06% CRDO $165.22 -20.04% MRVL $206.48 -1.86%

Credo Technology Group Holding Ltd (NASDAQ: CRDO) experienced a sharp selloff on Wednesday, with shares dropping 20.04% to close at $165.22. The decline came even as the company reported record quarterly revenue, highlighting the market's growing unease with the stock's valuation.

Trading volume surged to 29.94 million shares, more than six times the average daily volume, as investors rushed to exit positions. The stock opened at $188.64, well below Tuesday's close of $206.63, and continued to slide throughout the session, hitting a low of $161.95 before closing at $165.22.

Revenue Surge vs. Margin Pressure

Credo reported fiscal first-quarter revenue of $479.0 million, a 114.7% increase year-over-year and a 9.6% sequential gain. Adjusted earnings came in at $1.20 per diluted share, beating consensus estimates. However, the company's GAAP gross margin declined to 64.5% from 68.2% in the prior quarter, a drop of 3.7 percentage points. The non-GAAP gross margin was more stable at 68.0%, down just 0.3 points sequentially, reflecting $11.0 million in amortization of acquired intangibles.

The margin outlook has become a focal point for investors. Credo projects second-quarter revenue between $525 million and $535 million, with the midpoint implying 10.6% sequential growth. However, the company also expects GAAP gross margin to dip further to 63.9% at the midpoint, while non-GAAP gross margin is expected to hold at 68.0%.

Valuation Concerns

The stock's decline was exacerbated by valuation concerns. Credo closed with a market capitalization of $31.05 billion, which translates to approximately 14.6 times the annualized midpoint of management's revenue guidance for the next quarter. This rich multiple left little room for disappointment, and the market's reaction suggests that even strong growth may not justify such a premium.

Peer stocks Marvell Technology (MRVL) and Astera Labs (ALAB) fell just 1.86% and 2.06%, respectively, indicating that the selloff was company-specific rather than sector-wide.

Analyst Optimism Persists

Despite the sharp drop, Wall Street remains largely bullish on Credo. Of 14 analysts surveyed, 13 have buy ratings, with an average price target of $292.08. Even the lowest target of $235 is 42% above Wednesday's closing price. This optimism, however, is tempered by significant concentration risk: Credo's top four customers accounted for 84% of revenue in the quarter, with the largest customer representing 33%.

Execution is Key

Looking ahead, the focus shifts to execution. Management's guidance for $530 million in revenue and adjusted gross margin near 68% will be closely watched. If the company fails to meet these targets, the current sales multiple offers little downside protection. The market is clearly demanding more than just strong demand language; it wants to see tangible results.

CEO Bill Brennan highlighted the company's broad portfolio, covering "connectivity from millimeters to kilometers, with solutions across optics and copper," and linked rising demand to AI infrastructure expansion. However, investors are now looking for evidence that this demand translates into sustainable profitability.

The selloff serves as a reminder that even high-growth companies can face sharp corrections when valuations outpace fundamentals. Credo's ability to navigate margin pressures and customer concentration will be critical in the coming quarters.

This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Market data may be delayed. Always conduct your own research and consult a licensed financial advisor before making investment decisions.

Related Articles

View All →